Semaglutide works by binding to GLP-1 receptors in the brain, reducing appetite, slowing down stomach emptying, and increasing feelings of fullness
Giving PEBG (2500 mg/kg, p.o., over 4 months) resulted in higher levels of 2-hydroxybenzoic acid, hydroxyphenylpropionic acid, and dihydroxyphenyl valerolactone in 12-month-old triple transgenic mice, and these increases were positively associated with better memory performance [21]
With millions of patients now on these drugs, the podiatric consequences of rapid fat loss are surfacing at scale for the first time
GLP-1 receptor agonists mimic the action of a hormone glucagon-like peptide 1 that the gut secretes after eating
Lipid-induced insulin resistance in skeletal muscle: the chase for the culprit goes from total intramuscular fat to lipid intermediates, and finally to species of lipid intermediates
Concerning the lipid metabolism, there is compelling evidence showing that in some cancer types the fatty acid utilization is increased, while in others this pathway is down-regulated